Bayer Buys Merck Consumer Biz, Aiming For Top Of Global OTC Industry

The $14.2 billion deal is “a major milestone on our path toward global leadership” in OTC sales, says Bayer Chairman Marijn Dekkers. The acquisition focuses on expanding international sales of Merck products including the Coppertone sunscreen, Claritin allergy and MiraLax constipation lines.